Céline received a 11.4 Mio DKK Hallas-Møller Ascending Investigator grant from the Novo Nordisk foundation for the project entitled “Reverting brain lipid changes associated with Parkinson’s Disease pathology in patients’ neuronal cells”.
This project aims at testing novel strategies to revert lipid changes associated with Parkinson’s Disease and decrease protein clumps in neuronal cells.
Read more here.
Galvagnion Group 